SCHEMBL6785342

SCHEMBL6785342

Cn1[c]nc2c[c]cnc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067409 0.69 SLC9A1 (0.36)
SCHEMBL2067210 0.69 GRM5 (0.38)
SCHEMBL2067579 0.67 CDK9 (0.35)
SCHEMBL2066493 0.63 CSNK2A2 (0.32)
SCHEMBL21054657 0.62 ADORA2A (0.39)
SCHEMBL797323 0.60 PIK3CB (0.34)
SCHEMBL3483052 0.60 PI4KA (0.35)
SCHEMBL3513580 0.59 HSD17B10 (0.49)
SCHEMBL3483229 0.59
SCHEMBL2392585 0.59 ADORA2A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710055-B2 INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBO QUINOLINE-8-SULFONYLAMINO)-INDOLE BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2004-03-23 US claimed
US-20030004181-A1 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-02 US claimed